The multi-factorial nature of clinical multidrug resistance in cancer

YG Assaraf, A Brozovic, AC Gonçalves… - Drug resistance …, 2019 - Elsevier
Curative cancer therapy remains a major challenge particularly in cancers displaying
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …
被引用次数：421 相关文章

The multi-factorial nature of clinical multidrug resistance in cancer

YG Assaraf, A Brozovic… - Drug resistance …, 2019 - pubmed.ncbi.nlm.nih.gov
Curative cancer therapy remains a major challenge particularly in cancers displaying
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …

The multi-factorial nature of clinical multidrug resistance in cancer

YG Assaraf, A Brozovic, AC Gonçalves… - DRUG RESISTANCE …, 2019 - usiena-air.unisi.it
Curative cancer therapy remains a major challenge particularly in cancers displaying
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …

[引用][C] The multi-factorial nature of clinical multidrug resistance in cancer

YG Assaraf, A Brozovic, AC Gonçalves… - Drug Resistance …, 2019 - cir.nii.ac.jp
The multi-factorial nature of clinical multidrug resistance in cancer | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

The multi-factorial nature of clinical multidrug resistance in cancer

YG Assaraf, A Brozović, AC Gonçalves, D Jurkovicova… - 2019 - fulir.irb.hr
Curative cancer therapy remains a major challenge particularly in cancers displaying
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …

The multi-factorial nature of clinical multidrug resistance in cancer

YG Assaraf, A Brozović, AC Gonçalves… - Drug resistance …, 2019 - croris.hr
Sažetak Curative cancer therapy remains a major challenge particularly in cancers
displaying multidrug resistance (MDR). The MDR phenotype is characterized by cross …

The multi-factorial nature of clinical multidrug resistance in cancer.

YG Assaraf, A Brozovic, AC Gonçalves… - … and Commentaries in …, 2019 - europepmc.org
Curative cancer therapy remains a major challenge particularly in cancers displaying
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …

The multi-factorial nature of clinical multidrug resistance in cancer

YG Assaraf, A Brozović, AC Gonçalves… - Drug resistance …, 2019 - croris.hr
Sažetak Curative cancer therapy remains a major challenge particularly in cancers
displaying multidrug resistance (MDR). The MDR phenotype is characterized by cross …